Implantable Cardioverter Defibrillator (ICD) Devices Market Size, Share and Trends Analysis | Global | 2022-2028 | MedCore | Includes: Single-Chamber ICDs, Dual-Chamber ICDs,

  • Year: 2022
  • Scope: 10 Years
  • Region: Global
  • Pages: 104
  • Published Date: 11/24/2022
  • Type: MedCore

Product Description

Overall, the global ICD market was valued at over $3.6 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.1% to reach $4.7 billion by 2028.

Throughout this medical market research, we analyzed global ICD companies across more than 70 countries and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

The full report suite on the global market for implantable cardioverter defibrillators (ICDs) includes single-chamber ICDs, dual-chamber ICDs and subcutaneous ICDs (S-ICDs).

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2028, and Historical Data to 2018
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

PROCEDURE NUMBERS

The procedure numbers for the global ICD market includes single-chamber ICD, dual-chamber ICD and S-ICD procedures for both initial placement and replacement. Aside from the decline and recovery in 2020 and 2021, associated with the delay and cancellation of elective procedures, the total number of ICD procedures is projected to grow at a mid-single-digit rate over the forecast period.

GLOBAL ICD MARKET TRENDS

global ICD marketIn 2021, the total cardiac resynchronization therapy (CRT) device market experienced an increase from the previous year. CRTs are the most expensive device category within the CRM industry; however, the additional benefits of CRT-D devices over implantable cardioverter defibrillators (ICD) are appealing enough to overcome the price difference.

GLOBAL ICD MARKET SHARE INSIGHTS

Overall, within the global ICD market the top three dominant competitors are: Medtronic, Abbott, and Boston Scientific.

global ICD marketIn 2021, Medtronic led the ICD market with single-chamber and dual-chamber devices. Medtronic pioneered the development of ICDs and has long been the leading manufacturer. Medtronic sells a range of pacemakers, including CobaltTM, CromeTM, EveraTMMRI and some others.

GLOBAL ICD MARKET SEGMENTATION SUMMARY

  • Single-chamber ICDs
  • Dual-chamber ICDs
  • Subcutaneous ICDs

RESEARCH SCOPE SUMMARY

Report Attribute Details
Regions North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan,   Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand,   Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2021
Forecast 2022-2028
Historical Data 2018-2021
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

  • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

 

FREE Sample Report

Table of Contents

Implantable Cardioverter defibrillator Market
7.1 Executive Summary
7.1.1 Global Implantable Cardioverter Defibrillator Market Overview
7.1.2 Competitive Analysis
7.1.3 Procedures Included
7.1.4 Markets Included
7.1.5 Regions Included
7.2 Introduction
7.3 Procedure Numbers
7.3.1 Total ICD Placement Procedures
7.3.2 Initial Placement ICD Procedures
7.3.3 Replacement ICD Procedures
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total ICD Market
7.5.2 Single-Chamber ICD Market
7.5.2.1 Initial Placement Single-Chamber ICD Market
7.5.2.2 Replacement Single-Chamber ICD Market
7.5.3 Dual-Chamber ICD Market
7.5.3.1 Initial Placement Dual-Chamber ICD Market
7.5.3.2 Replacement Dual-Chamber ICD Market
7.5.4 S-ICD Market
7.5.4.1 Initial Placement S-ICD Market
7.5.4.2 Replacement S-ICD Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis

Companies Included:

Medtronic
Abbott
Boston Scientific
Biotronik
MicroPort

List of Charts

Chart 7‑1: ICD Market, Global, 2018 – 2028
Chart 7‑2: ICD Placement Procedures, Global, 2021
Chart 7‑3: ICD Placement Procedures by Segment, Global, 2018 – 2028
Chart 7‑4: ICD Market by Segment, Global, 2018 – 2028
Chart 7‑5: ICD Market by Region, Global, 2018 – 2028
Chart 7‑6: Leading Competitors, ICD Market, Global, 2021

List of Figures

Figure 7‑1: ICD Procedures Covered
Figure 7‑2: ICD Markets Covered
Figure 7‑3: ICD Regions Covered, Global (1 of 2)
Figure 7‑4: ICD Regions Covered, Global (2 of 2)
Figure 7‑5: ICD Placement Procedures by Segment, Global, 2018 – 2028
Figure 7‑6: ICD Placement Procedures by Region, Global, 2018 – 2028
Figure 7‑7: ICD Placement Procedures by Country, North America, 2018 – 2028
Figure 7‑8: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 7‑9: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 7‑10: ICD Placement Procedures by Country, Western Europe, 2018 – 2028
Figure 7‑11: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 7‑12: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 7‑13: ICD Placement Procedures by Country, Middle East, 2018 – 2028
Figure 7‑14: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 7‑15: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 7‑16: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 7‑17: ICD Placement Procedures by Country, Africa, 2018 – 2028
Figure 7‑18: Initial Placement ICD Procedures by Region, Global, 2018 – 2028
Figure 7‑19: Initial Placement ICD Procedures by Country, North America, 2018 – 2028
Figure 7‑20: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 7‑21: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 7‑22: Initial Placement ICD Procedures by Country, Western Europe, 2018 – 2028
Figure 7‑23: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 7‑24: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 7‑25: Initial Placement ICD Procedures by Country, Middle East, 2018 – 2028
Figure 7‑26: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 7‑27: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 7‑28: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 7‑29: Initial Placement ICD Procedures by Country, Africa, 2018 – 2028
Figure 7‑30: Replacement ICD Procedures by Region, Global, 2018 – 2028
Figure 7‑31: Replacement ICD Procedures by Country, North America, 2018 – 2028
Figure 7‑32: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 7‑33: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 7‑34: Replacement ICD Procedures by Country, Western Europe, 2018 – 2028
Figure 7‑35: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 7‑36: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 7‑37: Replacement ICD Procedures by Country, Middle East, 2018 – 2028
Figure 7‑38: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 7‑39: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 7‑40: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 7‑41: Replacement ICD Procedures by Country, Africa, 2018 – 2028
Figure 7‑42: ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑43: ICD Market by Region, Global, 2018 – 2028 (US$M)
Figure 7‑44: ICD Market, Global, 2018 – 2028
Figure 7‑45: Units Sold by Region, ICD Market, Global, 2018 – 2028
Figure 7‑46: Average Selling Price by Region, ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑47: Market Value by Region, ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑48: Single-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑49: Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑50: Units Sold by Region, Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑51: Average Selling Price by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑52: Market Value by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑53: Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑54: Units Sold by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑55: Average Selling Price by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑56: Market Value by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑57: Replacement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑58: Units Sold by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑59: Average Selling Price by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑60: Market Value by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑61: Dual-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑62: Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑63: Units Sold by Region, Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑64: Average Selling Price by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑65: Market Value by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑66: Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑67: Units Sold by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑68: Average Selling Price by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑69: Market Value by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑70: Replacement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑71: Units Sold by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑72: Average Selling Price by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑73: Market Value by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑74: S-ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑75: S-ICD Market, Global, 2018 – 2028
Figure 7‑76: Units Sold by Region, S-ICD Market, Global, 2018 – 2028
Figure 7‑77: Average Selling Price by Region, S-ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑78: Market Value by Region, S-ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑79: Initial Placement S-ICD Market, Global, 2018 – 2028
Figure 7‑80: Units Sold by Region, Initial Placement S-ICD Market, Global, 2018 – 2028
Figure 7‑81: Average Selling Price by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑82: Market Value by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑83: Replacement S-ICD Market, Global, 2018 – 2028
Figure 7‑84: Units Sold by Region, Replacement S-ICD Market, Global, 2018 – 2028
Figure 7‑85: Average Selling Price by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑86: Market Value by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑87: Leading Competitors, ICD Market, Global, 2021
Figure 7‑88: Leading Competitors by Region, ICD Market, Global, 2021
Figure 7‑89: Leading Competitors by Region, Single-Chamber ICD Market, Global, 2021
Figure 7‑90: Leading Competitors by Region, Dual-Chamber ICD Market, Global, 2021

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

The full report suite on the global market for cardiac resynchronization therapy (CRT) devices includes cardiac resynchronization therapy-pacemakers (CRT-Ps) and cardiac resynchronization therapy-defibrillators (CRT-Ds).

  • 2022
  • 10 Years
  • Global
  • 11/24/2022
  • 104
  • MedCore
SKU: iDATA_GLCRM22_MC_ICD Categories: , ,
Request Sample Sheets Request Customization
Related Reports
+

REQUEST SAMPLE SHEETS

+

REQUEST CUSTOMIZATION

+

Free Sample Report Form

+

See Report Summary

0
    0
    Your Cart
    Your cart is emptyReturn to Report Library